 |
Previous Article | Next Article 
The Journal of Neuroscience, April 15, 2002, 22(8):3262-3268
cAMP Response Element-Binding Protein Is Essential
for the Upregulation of Brain-Derived Neurotrophic Factor
Transcription, But Not the Behavioral or Endocrine Responses to
Antidepressant Drugs
Alana C.
Conti1,
John
F.
Cryan2,
Ashutosh
Dalvi2,
Irwin
Lucki1, 2, 3, and
Julie A.
Blendy1, 3
Departments of 1 Pharmacology and
2 Psychiatry, and 3 Center for Neurobiology and
Behavior, University of Pennsylvania, Philadelphia, Pennsylvania
19104-6084
Antidepressant drugs activate the cAMP signal transduction pathway
through a variety of monoamine neurotransmitter receptors. Recently,
molecular studies have identified a role for cAMP response element-binding protein (CREB) in the mechanism of action of
chronically administered antidepressant drugs. However, the function of
CREB in the behavioral and endocrine responses to these drugs has not been thoroughly investigated. We have used CREB-deficient mice to study
the effects of two antidepressants, desipramine (DMI) and fluoxetine
(FLX), in behavioral, endocrine, and molecular analyses. Behaviorally,
CREB-deficient mice and wild-type mice respond similarly to DMI and FLX
administration in the forced swim test and tail suspension test.
Furthermore, the ability of DMI to suppress an acute corticosterone
response after swim stress is maintained in CREB-deficient mice.
However, upregulation of a molecular target of CREB, BDNF, is abolished
in the CREB-deficient mice after chronic administration of DMI. These
data are the first to demonstrate that CREB activation is upstream of
BDNF mechanistically in response to antidepressant drug treatment.
Therefore, although behavioral and endocrine responses to
antidepressants may occur by CREB-independent mechanisms, CREB is
critical to target gene regulation after chronic drug administration,
which may contribute to long-term adaptations of the system to
antidepressant drug treatment.
Key words:
CREB; BDNF; antidepressant; gene expression; forced
swimming test; tail suspension test; desipramine; fluoxetine
Copyright © 2002 Society for Neuroscience 0270-6474/02/2283262-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
R.H. Belmaker and G. Agam
Major Depressive Disorder
N. Engl. J. Med.,
January 3, 2008;
358(1):
55 - 68.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Gur, A. C. Conti, J. Holden, A. J. Bechtholt, T. E. Hill, I. Lucki, J. E. Malberg, and J. A. Blendy
cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response
J. Neurosci.,
July 18, 2007;
27(29):
7860 - 7868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Wood, M. A. Attner, A. M.M. Oliveira, P. K. Brindle, and T. Abel
A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes
Learn. Mem.,
September 1, 2006;
13(5):
609 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yagasaki, T. Numakawa, E. Kumamaru, T. Hayashi, T.-P. Su, and H. Kunugi
Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release
J. Biol. Chem.,
May 5, 2006;
281(18):
12941 - 12949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tardito, J. Perez, E. Tiraboschi, L. Musazzi, G. Racagni, and M. Popoli
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
Pharmacol. Rev.,
March 1, 2006;
58(1):
115 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Slattery, S. Desrayaud, and J. F. Cryan
GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent
J. Pharmacol. Exp. Ther.,
January 1, 2005;
312(1):
290 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Albert and S. Lemonde
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Neuroscientist,
December 1, 2004;
10(6):
575 - 593.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Kreibich and J. A. Blendy
cAMP Response Element-Binding Protein Is Required for Stress But Not Cocaine-Induced Reinstatement
J. Neurosci.,
July 28, 2004;
24(30):
6686 - 6692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Conti, Y.-C. Kuo, R. J. Valentino, and J. A. Blendy
Inducible cAMP Early Repressor Regulates Corticosterone Suppression after Tricyclic Antidepressant Treatment
J. Neurosci.,
February 25, 2004;
24(8):
1967 - 1975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Einat, P. Yuan, T. D. Gould, J. Li, J. Du, L. Zhang, H. K. Manji, and G. Chen
The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
J. Neurosci.,
August 13, 2003;
23(19):
7311 - 7316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dwivedi, J. S. Rao, H. S. Rizavi, J. Kotowski, R. R. Conley, R. C. Roberts, C. A. Tamminga, and G. N. Pandey
Abnormal Expression and Functional Characteristics of Cyclic Adenosine Monophosphate Response Element Binding Protein in Postmortem Brain of Suicide Subjects
Arch Gen Psychiatry,
March 1, 2003;
60(3):
273 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|